Table 1.
Baseline clinical features
| Characteristics | Development cohort (n = 235) | Validation cohort (n = 84) |
|---|---|---|
| Mean ± SD/No (%) | Mean ± SD/No (%) | |
| Age, year | 54.95 ± 11.92 | 55.00 ± 11.58 |
| Sex | ||
| Male | 163 (69.36%) | 60 (71.43%) |
| Female | 72 (30.64%) | 24 (28.57%) |
| TNM stage | ||
| I | 43 (18.30%) | 6 (7.14%) |
| II | 66 (28.09%) | 18 (21.43%) |
| III | 83 (35.32%) | 37 (44.05%) |
| IV | 43 (18.30) | 23 (27.38%) |
| Tumor stage | ||
| T1 | 42 (17.87%) | 6 (7.14%) |
| T2 | 25 (10.64%) | 5 (5.95%) |
| T3 | 76 (32.34%) | 29 (34.52%) |
| T4 | 92 (39.15%) | 44 (52.38%) |
| Node stage | ||
| N0 | 62 (26.38%) | 15 (17.86%) |
| N1 | 41 (17.45%) | 12 (14.29%) |
| N2 | 43 (18.30%) | 17 (20.24%) |
| N3 | 89 (37.87%) | 40 (47.62%) |
| Metastasis | ||
| No | 192 (81.70%) | 61 (72.62%) |
| Yes | 43 (18.30%) | 23 (27.38%) |
| Location | ||
| 1 | 33 (14.04%) | 14 (16.67%) |
| 2 | 56 (23.83%) | 23 (27.38%) |
| 3 | 109 (46.38%) | 32 (38.10%) |
| 4 | 37 (15.74%) | 15 (17.86%) |
| AST, U/L | ||
| ≤ 22.8 | 17.51 ± 2.66 | 17.65 ± 3.70 |
| > 22.8 | 35.15 ± 21.05 | 44.82 ± 34.85 |
| ALT, U/L | ||
| ≤ 30.1 | 16.67 ± 5.37 | 17.89 ± 5.94 |
| > 30.1 | 56.41 ± 41.03 | 65.97 ± 47.55 |
| LDH, U/L | ||
| ≤ 168.7 | 142.59 ± 16.72 | 146.24 ± 17.25 |
| > 168.7 | 206.02 ± 54.78 | 289.90 ± 353.72 |
| GGT, U/L | ||
| ≤ 26.9 | 16.52 ± 5.09 | 17.39 ± 5.02 |
| > 26.9 | 51.02 ± 45.46 | 55.67 ± 57.97 |
| TBA, μmol/L | ||
| ≤ 5.4 | 2.86 ± 1.25 | 3.21 ± 1.22 |
| > 5.4 | 12.76 ± 10.41 | 13.10 ± 8.99 |
| ALP, U/L | ||
| ≤ 80 | 61.72 ± 11.77 | 60.94 ± 10.51 |
| > 80 | 98.59 ± 25.85 | 120.26 ± 83.86 |
| ALB, g/L | ||
| ≤ 38.8 | 34.86 ± 3.74 | 36.16 ± 1.97 |
| > 38.8 | 42.56 ± 2.42 | 43.03 ± 2.48 |
| TBIL, μmol/L | ||
| ≤ 7.3 | 5.78 ± 1.26 | 5.98 ± 0.94 |
| > 7.3 | 13.11 ± 4.77 | 12.40 ± 4.78 |
| ApoA1, g/L | ||
| ≤ 1.1 | 0.96 ± 0.13 | 0.96 ± 0.12 |
| > 1.1 | 1.34 ± 0.19 | 1.33 ± 0.21 |
| ApoB, g/L | ||
| ≤ 1.1 | 0.84 ± 0.16 | 0.82 ± 0.16 |
| > 1.1 | 1.44 ± 0.79 | 1.17 ± 0.04 |
| PT, S | ||
| ≤ 11.9 | 11.11 ± 0.47 | 11.09 ± 0.52 |
| > 11.9 | 12.56 ± 0.67 | 12.95 ± 1.66 |
| Fbg, g/L | ||
| ≤ 3.6 | 2.63 ± 0.56 | 2.68 ± 0.54 |
| > 3.6 | 4.35 ± 0.67 | 4.27 ± 0.70 |
Data are presented as mean (SD) or N (%)